NTCOC
ARRY

Northern Trust Company of Connecticut’s Array Biopharma Inc ARRY Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$50K Hold
10,023
– – ﹤0.01% 1937
2013
Q3 		$62K Hold
10,023
– – ﹤0.01% 1892
2013
Q2 		$46K Buy
+10,023
New +$53.9K ﹤0.01% 1889

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Company of Connecticut's ARRY Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Array Biopharma Inc (ARRY) position steady in Q4 2013 at 10,023 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

Northern Trust Company of Connecticut first reported a position in ARRY in Q2 2013 and has held it in 3 quarters since. The position peaked at $62K in Q3 2013. 143 funds tracked by Wall St. Rank hold ARRY as of Q4 2013.

  • Northern Trust Company of Connecticut held 10,023 shares of Array Biopharma Inc worth $50K as of Q4 2013.
  • Northern Trust Company of Connecticut left its Array Biopharma Inc share count unchanged in Q4 2013.
  • Array Biopharma Inc made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1937 holding.
  • Northern Trust Company of Connecticut first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Array Biopharma Inc position peaked at $62K in Q3 2013.
  • 143 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.